Patient Comfort During High Flow Nasal Cannula Versus Nasal Continuous Airway Pressure (CPAP)
Primary Purpose
Respiratory Distress Syndrome, Newborn, Medical Device Discomfort
Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Respiratory support HFNC
Respiratory support NCPAP
Sponsored by
About this trial
This is an interventional treatment trial for Respiratory Distress Syndrome, Newborn focused on measuring High flow nasal cannula, Discomfort
Eligibility Criteria
Inclusion Criteria:
Preterm infants admitted to the NICU at University Hospital of North Norway, Tromsoe, Norway (single center study)
- Gestational age (GA) < 34 weeks
- Corrected age < 34 weeks
- Receiving nasal CPAP for respiratory distress
- Respiratory "stable": FiO2 < 30%, pCO2 < 8,5 kPa and pH > 7.25.
- GA < 29 weeks: Respiratory "stable" over last 72 h.
- GA 29-33 weeks: Respiratory "stable" over last 24 h.
Exclusion Criteria:
- Congenital anomalies
- Ongoing treatment for hypoglycemia or infection
- Other intercurrent disease requiring frequent blood sampling
Sites / Locations
- University Hospital of North Norway
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
HFNC
nCPAP
Arm Description
High flow nasal cannula
Nasal CPAP
Outcomes
Primary Outcome Measures
Patient comfort (EDIN score)
EDIN score (neonatal pain and comfort score) is a validated scoring system to assess pain and comfort in term and preterm infants. The cumulative EDIN score, based on three evaluations/24 h, is recorded for each 24 h epoch with HFNC or CPAP, respectively. The change in EDIN score between the two 24 h epochs are assessed.
Secondary Outcome Measures
Noise
Surrounding noise (dB)is measured twice daily during the 2 x 24 (48) h study period; twice during CPAP and twice during HFNC.
Parental satisfaction
3 questions related to parental satisfaction are asked by the end of each 24 h epoch with either CPAP or HFNC.
Stress hormone response (salivary cortisol)
Salivary cortisol is used as a marker of stress hormone response. Salivary cortisol is collected twice (10 AM and 10 PM) for every 24 h epoch; a total of 4 measurements.
Full Information
NCT ID
NCT01526226
First Posted
January 2, 2012
Last Updated
June 23, 2017
Sponsor
University Hospital of North Norway
1. Study Identification
Unique Protocol Identification Number
NCT01526226
Brief Title
Patient Comfort During High Flow Nasal Cannula Versus Nasal Continuous Airway Pressure (CPAP)
Official Title
Patient Comfort During High Flow Nasal Cannula (HFNC)Versus Nasal Continuous Airway Pressure (CPAP): a Cross Over Randomised Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2013
Overall Recruitment Status
Completed
Study Start Date
February 2012 (undefined)
Primary Completion Date
May 2013 (Actual)
Study Completion Date
May 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital of North Norway
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Preterm children are at increased risk for developing lung disease due to immature lungs. Non-invasive ventilation (NIV) support is increasingly used as treatment. Nasal continuous positive airway pressure (nCPAP) is the most common NIV-mode. Recently, high flow nasal cannulas (HFNC) have become an alternative NIV-mode. Both nCPAP and HFNC provide increased pressure in the airways aiming to keep the lungs open. With nCPAP it is common to use short binasal prongs that fill the nostrils completely and are pressed tightly over the nose. With HFNC oxygen/air is administered via two small, thin cannulas located just inside the nostrils, but the nostrils are not blocked.
The aim of this study is to compare patient comfort in premature infants treated with nCPAP and HFNC. The investigators hypothesis is that HFNC increases patient comfort.
The study is a randomized cross over study (2 x 24 hours). Children eligible for inclusion should be born before 34 weeks of gestation and have moderate respiratory distress, thus be "in need" of nCPAP. During the study period (48 hours) the investigators will consider how the child tolerates treatment with nCPAP versus HFNC. Primary outcome is patient comfort assessed with the EDIN-score (Neonatal pain and comfort score). Secondary outcomes are stress hormone response (cortisol in saliva), surrounding noise and parental satisfaction. The child's breathing pattern will be carefully monitored. The study involves no extra painful investigations.
The investigators plan to recruit 20 patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Distress Syndrome, Newborn, Medical Device Discomfort
Keywords
High flow nasal cannula, Discomfort
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
24 (Actual)
8. Arms, Groups, and Interventions
Arm Title
HFNC
Arm Type
Experimental
Arm Description
High flow nasal cannula
Arm Title
nCPAP
Arm Type
Active Comparator
Arm Description
Nasal CPAP
Intervention Type
Device
Intervention Name(s)
Respiratory support HFNC
Other Intervention Name(s)
HFNC; Fisher and Paykel
Intervention Description
In the cross over study 2 types of respiratory support are compared; HFNC versus nCPAP
Intervention Type
Device
Intervention Name(s)
Respiratory support NCPAP
Other Intervention Name(s)
NCPAP: Infant Flow (CareFusion)
Intervention Description
In the cross over study 2 types of respiratory support are compared; HFNC versus nCPAP
Primary Outcome Measure Information:
Title
Patient comfort (EDIN score)
Description
EDIN score (neonatal pain and comfort score) is a validated scoring system to assess pain and comfort in term and preterm infants. The cumulative EDIN score, based on three evaluations/24 h, is recorded for each 24 h epoch with HFNC or CPAP, respectively. The change in EDIN score between the two 24 h epochs are assessed.
Time Frame
48 h (CPAP 24 h and HFNC 24 h); cumulative EDIN score for each 24 epoch is calculated and a change between the two interventions are assessed
Secondary Outcome Measure Information:
Title
Noise
Description
Surrounding noise (dB)is measured twice daily during the 2 x 24 (48) h study period; twice during CPAP and twice during HFNC.
Time Frame
Measured at 10 AM and 10 PM over 48 h (4 measurements)
Title
Parental satisfaction
Description
3 questions related to parental satisfaction are asked by the end of each 24 h epoch with either CPAP or HFNC.
Time Frame
Three questions answered after 24 h and 48 h
Title
Stress hormone response (salivary cortisol)
Description
Salivary cortisol is used as a marker of stress hormone response. Salivary cortisol is collected twice (10 AM and 10 PM) for every 24 h epoch; a total of 4 measurements.
Time Frame
Measured at 10 AM and 10 PM over 48 h (4 measurements)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Weeks
Maximum Age & Unit of Time
34 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Preterm infants admitted to the NICU at University Hospital of North Norway, Tromsoe, Norway (single center study)
Gestational age (GA) < 34 weeks
Corrected age < 34 weeks
Receiving nasal CPAP for respiratory distress
Respiratory "stable": FiO2 < 30%, pCO2 < 8,5 kPa and pH > 7.25.
GA < 29 weeks: Respiratory "stable" over last 72 h.
GA 29-33 weeks: Respiratory "stable" over last 24 h.
Exclusion Criteria:
Congenital anomalies
Ongoing treatment for hypoglycemia or infection
Other intercurrent disease requiring frequent blood sampling
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Claus Klingenberg, MD, PhD
Organizational Affiliation
University Hospital of North Norway, Tromsø, Norway
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital of North Norway
City
Tromsø
ZIP/Postal Code
N-9038
Country
Norway
12. IPD Sharing Statement
Citations:
PubMed Identifier
21563154
Citation
Wilkinson D, Andersen C, O'Donnell CP, De Paoli AG. High flow nasal cannula for respiratory support in preterm infants. Cochrane Database Syst Rev. 2011 May 11;(5):CD006405. doi: 10.1002/14651858.CD006405.pub2.
Results Reference
background
PubMed Identifier
24225220
Citation
Klingenberg C, Pettersen M, Hansen EA, Gustavsen LJ, Dahl IA, Leknessund A, Kaaresen PI, Nordhov M. Patient comfort during treatment with heated humidified high flow nasal cannulae versus nasal continuous positive airway pressure: a randomised cross-over trial. Arch Dis Child Fetal Neonatal Ed. 2014 Mar;99(2):F134-7. doi: 10.1136/archdischild-2013-304525. Epub 2013 Nov 13.
Results Reference
derived
Learn more about this trial
Patient Comfort During High Flow Nasal Cannula Versus Nasal Continuous Airway Pressure (CPAP)
We'll reach out to this number within 24 hrs